...
首页> 外文期刊>Hepato-gastroenterology. >Changes of ammonia levels in patients with acute on chronic liver failure treated by plasma exchange.
【24h】

Changes of ammonia levels in patients with acute on chronic liver failure treated by plasma exchange.

机译:急性慢性肝衰竭患者氨水量的变化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Acute on chronic liver failure (AoCLF) is associated with a high mortality rate. Plasma exchange (PE) is useful to bridge AoCLF patients to liver transplantation. The aim of this study was to assess the effects of PE on plasma ammonia levels (PAL) in AoCLF patients.Seventy patients with AoCLF in 2 groups (PE plus standard medical treatment group, n = 32; and standard medical treatment group, n = 38) were enrolled in study. PAL was detected on admission and on days 7, 14, 21, and 30 during hospitalization.All AoCLF patients showed PAL more than the upper limit of the normal range. More dramatic decreased in the PE survivors (form 116.8 +/- 36.3 to 44.8 +/- 16.3, p < 0.01) than the medical survivors (form 105.7 +/- 30.2 to 57.1 +/- 20.3, p < 0.05) after 30 days of treatment. Furthermore, PAL after medical treatment were still higher than those of PE treatment in the survivors (57.1 +/- 20.3 vs. 44.8 +/- 16.3, p < 0.05). Among the non-survivors in the medical group, PAL remained at high levels throughout the examination period. Importantly, an increased PAL associated with high mortality and reduced survival time of AoCLF patients.Ammonia may be important in the pathogenesis of the AoCLF and PE may represent a reliable hepatic support device for AoCLF.
机译:慢性肝功能衰竭(AoClF)急性患者与高死亡率有关。血浆交换(PE)可用于将Aoclf患者桥接到肝移植。本研究的目的是评估PE对血浆氨水量(PAL)的血浆氨水量(PAL)的作用。患有2组AOCLF的患者(PE加标准医疗组,N = 32;和标准医疗组,N = 38)注册研究。在入院期间,在入场时检测到PAL,在住院期间的第7,14,21和30天。所有的Aoclf患者均显示PAL比正常范围的上限更多。 PE幸存者(表格116.8 +/- 36.3至44.8 +/- 16.3,P <0.01)比医学幸存者(表格105.7 +/- 30.2至57.1 +/-20.3,P <0.05)在30天后治疗。此外,药物治疗后的PAL仍然高于幸存者中的PE治疗(57.1 +/-20.3与44.8 +/- 16.3,P <0.05)。在医学组的非幸存者中,PAL在整个考试期间仍处于高水平。重要的是,与高死亡率和降低Aoclf患者的生存时间相关的增加的PAl.amamonia在AOClF和PE的发病机制中可能是重要的,PE可以代表用于AOClF的可靠性肝脏支撑装置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号